GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2026)

GE HealthCare Technologies has reported Cash from Investing Activities for 5 years, with the latest figure at -$2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 514.25% year-over-year to -$2.5 billion; the trailing twelve-month figure through Mar 2026 stood at -$3.1 billion (down 177.14% YoY), and the FY2025 full-year result was -$1.0 billion, down 14.55% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$2.5 billion, down from -$269.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$84.0 million in Q2 2023, with the low at -$2.5 billion in Q1 2026.
• Historically, Cash from Investing Activities has averaged -$318.6 million across 5 years, with a median of -$148.0 million in 2025.
• Annual changes were most pronounced in 2025 — Cash from Investing Activities soared 36.1% — and 2026, when it slumped 514.25%.
• GE HealthCare Technologies' Cash from Investing Activities stood at -$95.0 million in 2022, then grew by 7.37% to -$88.0 million in 2023, then tumbled by 172.73% to -$240.0 million in 2024, then dropped by 12.08% to -$269.0 million in 2025, then sank by 829.37% to -$2.5 billion in 2026.
• The last three Cash from Investing Activities figures came in at -$2.5 billion (Q1 2026), -$269.0 million (Q4 2025), and -$148.0 million (Q3 2025), per Business Quant data.